340B prescription drugs delivery restrictions prohibition

This bill prohibits drug manufacturers from restricting how 340B prescription drugs are delivered to participating hospitals and clinics. It directly affects healthcare facilities enrolled in the federal 340B program, which provides discounted drugs to safety-net providers. The key provision bans delivery restrictions and classifies violations as "unfair or deceptive trade practices," allowing the attorney general to enforce the law. The bill also removes an expiration date (previously set for July 2027) that would have ended the restrictions.